RNA has firmly established itself as the therapeutic molecule of choice for the next generation of life-saving treatments.
However, efficiently and safely delivering RNA to target cells in patients remains a significant challenge. In many cases, less than 1% of the treatment reaches its intended target, limiting both its efficacy and safety.
At Crane Biosciences, we’ve developed a proprietary nanoparticle technology that ensures precise RNA delivery to a wide range of previously inaccessible tissues. This breakthrough enables groundbreaking treatments for conditions ranging from cancer to Alzheimer’s.
Our mission is to transform RNA delivery and save the lives of billions worldwide.
Want to learn more? Get in touch below.
